Original Source(s)
Related Content
What's Next for Prenatal Screening?
Review highlights gaps in understanding of fetal DNA in maternal blood that may be limiting prenatal testing
October 16, 2026
-
3 min
FDA expands talazoparib use in prostate cancer
The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .
by Mouj Hijazi
October 27, 2026
-
3 min